pan NADPH oxidase inhibitor (AptaBio/Delaware State University)

N/A

Report date: 2025/03/19 11:39:59
NME

Base Information

Drug Namepan NADPH oxidase inhibitor (AptaBio/Delaware State University)
Drug Alias NameNOX 1/2/4 inhibitor (AptaBio/Delaware State University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase 4 inhibitorsNADPH Oxidase 2 inhibitorsNADPH oxidase 1 inhibitors
TargetsNADPH Oxidase 2NADPH oxidase 1NADPH oxidase 4
Therapy Area/IndicationsNerve DegenerationParkinson DiseaseLewy Body Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDelaware State University
China Registration ClassN/A

Develop Information

Active CompaniesDelaware State UniversityAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationParkinson DiseaseLewy Body Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A